Abstract
Background: COVID-19 caused an unprecedented upsurge in scientific literature as the global community mobilized to combat the pandemic. Methods: This study employed bibliometric analysis to evaluate research trends, geographical distribution, international collaboration, and key thematic shifts based on publication outputs from 1991 to 2020. Results: The analysis revealed that while SARS and MERS triggered notable increases in research, COVID-19 caused a far more dramatic and sustained explosion in output. International collaboration intensified significantly, with the research focus evolving toward specific biological targets (e.g., Spike protein, ACE2) and clinical management. Conclusions: Global epidemics serve as extreme accelerators for scientific research and evolution, shifting the landscape from localized "skirmishes" to a "protracted battle."
Introduction
When a global health crisis emerges, the scientific community responds with a deluge of data. However, synthesizing this information to understand the broader trajectory of research can be challenging. This study provides a high-level "map" of how the scientific landscape regarding coronaviruses evolved over three decades. By analyzing over 25,000 papers, the researchers demonstrate how the field shifted from a niche area of virology into a global, multi-disciplinary "protracted battle" following the emergence of SARS, MERS, and finally, COVID-19.
The authors aim to distinguish the "skirmishes" of SARS (2003) and MERS (2012) from the "total war" of COVID-19. Using bibliometrics—the statistical analysis of academic publications—they provide a meta-view of how human knowledge about coronaviruses has been constructed, shared, and prioritized.
Methods and Data
The study utilized a rigorous bibliometric workflow to analyze 25,835 publications indexed in the Science Citation Index Expanded (SCIE) and the Social Science Citation Index (SSCI) between 1991 and June 30, 2020.
- Data Retrieval: Metadata was extracted using a comprehensive list of keywords including "Coronavirus*" and specific strains like "HCoV-NL63," "SARS-CoV," and "MERS-CoV."
- Geospatial and Network Analysis: ArcGIS (10.6) was used to map the geographical distribution of research output, while Gephi (0.9.2) visualized international collaboration networks.
- Keyword Categorization: To track thematic evolution, "hot keywords" were classified into six categories: Epidemiological features, Biological features, Immune response, Age/Sex, Diseases/Symptoms, and Diagnosis/Therapy.
Key Insights: The Evolution of a Global Response
The COVID-19 "Big Bang"
The most striking finding is the sheer scale of the COVID-19 response. In the first six months of 2020 alone, the scientific community produced 10,221 SCIE publications—nearly 40% of the total output from the preceding 30 years. This represents a fundamental shift in scientific productivity and priority.
From Localized Outbreaks to Global Collaboration
While SARS and MERS were handled as relatively localized "skirmishes" with short-lived research spikes, COVID-19 forced a sustained, multi-front scientific war. International co-authorship, which accounted for less than 1% of papers in the 1990s, surged to over 10% by 2020. The United States and China emerged as the central hubs of this global network, with the U.S. frequently serving as the primary bridge for international partnerships.
Shifting Scientific Targets
The focus of research evolved from general viral structures to highly specific molecular targets. Keywords such as "Spike protein," "ACE2 receptor," and "TMPRSS2" became dominant in 2020, reflecting a pivot toward targeted drug and vaccine development. Additionally, a significant portion of recent literature focuses on the "cytokine storm," highlighting the transition from viewing the virus as a simple infection to understanding it as a complex immunological crisis.
Results and Productivity
- Geographical Leaders: The U.S. led in total publications during the 1991–2002 and 2012–2019 periods. China took the top spot during the SARS era (2003–2011) and remained a top-two producer during the initial COVID-19 wave in 2020.
- Clinical Priorities: In 2020, "Pneumonia" and "rRT-PCR" were the most frequent keywords in their categories, emphasizing rapid diagnosis and acute respiratory care.
- Comorbidities: Research quickly identified "Diabetes" and "Hypertension" as the most studied comorbidities, allowing the community to prioritize high-risk populations early in the pandemic.
Limitations and Future Directions
The study's primary limitation is its temporal cutoff in June 2020. Consequently, it does not capture the subsequent waves of research regarding vaccine efficacy, variants (such as Delta or Omicron), or "Long COVID." Furthermore, the reliance on SCIE/SSCI databases may overlook preprints or regional journals not indexed in the Web of Science.
Future bibliometric research should explore the "traceability" of the virus and the long-term socio-economic impacts of the pandemic, which were only beginning to be addressed at the time of this analysis.
Conclusion
Epidemics act as powerful catalysts for scientific boom and evolution. The transition from the "skirmishes" of the early 21st century to the "protracted battle" of COVID-19 has permanently altered the landscape of coronavirus research, fostering unprecedented levels of international cooperation and clinical focus.
Summary updated